Review




Structured Review

Dexcom Inc rtcgm sts dexcom
Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes
Rtcgm Sts Dexcom, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rtcgm sts dexcom/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rtcgm sts dexcom - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring"

Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

Journal: Diabetes Technology & Therapeutics

doi: 10.1089/dia.2021.0007

Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes
Figure Legend Snippet: Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes

Techniques Used: Modification, Control

Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes
Figure Legend Snippet: Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes

Techniques Used:



Similar Products

90
Dexcom Inc rtcgm sts dexcom
Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes
Rtcgm Sts Dexcom, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rtcgm sts dexcom/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rtcgm sts dexcom - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dexcom Inc rtcgm sts
Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes
Rtcgm Sts, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rtcgm sts/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rtcgm sts - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes

Journal: Diabetes Technology & Therapeutics

Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

doi: 10.1089/dia.2021.0007

Figure Lengend Snippet: Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes

Article Snippet: Similarly, in a small observational study of 140 patients with diabetes (109 with T1D, 24 with T2D on insulin, and 7 with T2D on non-insulin therapies), rtCGM (STS Dexcom) was associated with a significant reduction in HbA1c by 0.4% in both T1D and T2D over 3 months compared to baseline.

Techniques: Modification, Control

Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes

Journal: Diabetes Technology & Therapeutics

Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

doi: 10.1089/dia.2021.0007

Figure Lengend Snippet: Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes

Article Snippet: Similarly, in a small observational study of 140 patients with diabetes (109 with T1D, 24 with T2D on insulin, and 7 with T2D on non-insulin therapies), rtCGM (STS Dexcom) was associated with a significant reduction in HbA1c by 0.4% in both T1D and T2D over 3 months compared to baseline.

Techniques:

Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes

Journal: Diabetes Technology & Therapeutics

Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

doi: 10.1089/dia.2021.0007

Figure Lengend Snippet: Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes

Article Snippet: In an early RCT examining CGM use by Garg et al., 91 insulin-requiring patients with diabetes (75 with T1D and 16 with T2D) were randomized to receive 3 days of rtCGM (STS, Dexcom) or masked CGM (control).

Techniques: Modification, Control

Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes

Journal: Diabetes Technology & Therapeutics

Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

doi: 10.1089/dia.2021.0007

Figure Lengend Snippet: Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes

Article Snippet: In an early RCT examining CGM use by Garg et al., 91 insulin-requiring patients with diabetes (75 with T1D and 16 with T2D) were randomized to receive 3 days of rtCGM (STS, Dexcom) or masked CGM (control).

Techniques: